IQVia’s Dreyer on how real-world data are poised to break new ground

Real-world data isn’t just about post-market analysis of new drugs and vaccines. With the pandemic putting the benefits on display, epidemiologists are finding new ways to use the data, and new data sources, to support the pandemic response.

In a conversation with BioCentury, Nancy Dreyer, CSO and SVP of real world solutions at IQVia Holdings Inc. (NYSE:IQV), discusses how IQVia is applying its data and analytical resources to an underserved COVID-19 research area...